Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8最新文献

筛选
英文 中文
Anticancer Therapeutic Strategies in Gliomas: Chemotherapy, Immunotherapy, and Molecularly Targeted Therapy in Adults 胶质瘤的抗癌治疗策略:化疗、免疫治疗和成人分子靶向治疗
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8 Pub Date : 2021-12-03 DOI: 10.2174/9781681089317121080009
X. Hu, K. Lian, Meng Wang, Xun Zhang
{"title":"Anticancer Therapeutic Strategies in Gliomas: Chemotherapy, Immunotherapy, and Molecularly Targeted Therapy in Adults","authors":"X. Hu, K. Lian, Meng Wang, Xun Zhang","doi":"10.2174/9781681089317121080009","DOIUrl":"https://doi.org/10.2174/9781681089317121080009","url":null,"abstract":"","PeriodicalId":199403,"journal":{"name":"Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114247810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast Cancer Vaccines: Current Status and Future Approach 乳腺癌疫苗:现状和未来方法
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8 Pub Date : 2021-12-03 DOI: 10.2174/9781681089317121080005
A. Gül, Sedef Erkunt Alak, Ceren Gül, T. Karakavuk, H. Can, M. Karakavuk, A. Köseoglu, M. Döşkaya, A. D. Döşkaya, E. Tuna, C. Ün, A. Gürüz, L. Yeniay
{"title":"Breast Cancer Vaccines: Current Status and Future Approach","authors":"A. Gül, Sedef Erkunt Alak, Ceren Gül, T. Karakavuk, H. Can, M. Karakavuk, A. Köseoglu, M. Döşkaya, A. D. Döşkaya, E. Tuna, C. Ün, A. Gürüz, L. Yeniay","doi":"10.2174/9781681089317121080005","DOIUrl":"https://doi.org/10.2174/9781681089317121080005","url":null,"abstract":"","PeriodicalId":199403,"journal":{"name":"Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8","volume":"120 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128097754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Towards Targeted Therapy: Anticancer Agents Targeting Cell Organelle Mitochondria 迈向靶向治疗:靶向细胞器线粒体的抗癌药物
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8 Pub Date : 2021-12-03 DOI: 10.2174/9781681089317121080008
M. Manjunath, B. Choudhary
{"title":"Towards Targeted Therapy: Anticancer Agents Targeting Cell Organelle Mitochondria","authors":"M. Manjunath, B. Choudhary","doi":"10.2174/9781681089317121080008","DOIUrl":"https://doi.org/10.2174/9781681089317121080008","url":null,"abstract":"","PeriodicalId":199403,"journal":{"name":"Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127112315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospects for Therapeutic Targeting of MicroRNAs in Brain Tumors 微rna靶向治疗脑肿瘤的前景
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8 Pub Date : 2021-12-03 DOI: 10.2174/9781681089317121080004
I. Gareev, O. Beylerli
{"title":"Prospects for Therapeutic Targeting of MicroRNAs in Brain Tumors","authors":"I. Gareev, O. Beylerli","doi":"10.2174/9781681089317121080004","DOIUrl":"https://doi.org/10.2174/9781681089317121080004","url":null,"abstract":"","PeriodicalId":199403,"journal":{"name":"Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8","volume":"91 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126845017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MDM2-p53 Antagonists Under Clinical Evaluation: A Promising Cancer Targeted Therapy for Cancer Patients Harbouring Wild-Type TP53 临床评估中的MDM2-p53拮抗剂:对携带野生型TP53的癌症患者的一种有希望的癌症靶向治疗
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8 Pub Date : 2021-12-03 DOI: 10.2174/9781681089317121080007
Maryam Zanjirband
{"title":"MDM2-p53 Antagonists Under Clinical Evaluation: A Promising Cancer Targeted Therapy for Cancer Patients Harbouring Wild-Type TP53","authors":"Maryam Zanjirband","doi":"10.2174/9781681089317121080007","DOIUrl":"https://doi.org/10.2174/9781681089317121080007","url":null,"abstract":"","PeriodicalId":199403,"journal":{"name":"Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127738204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Key Data Management Elements in Clinical Trials for Oncological Therapeutics 肿瘤治疗临床试验中的关键数据管理要素
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8 Pub Date : 2021-12-03 DOI: 10.2174/9781681089317121080003
Daniel Liu, Hua-long Sun, Yan Bo, Joe Wang
{"title":"Key Data Management Elements in Clinical Trials for Oncological Therapeutics","authors":"Daniel Liu, Hua-long Sun, Yan Bo, Joe Wang","doi":"10.2174/9781681089317121080003","DOIUrl":"https://doi.org/10.2174/9781681089317121080003","url":null,"abstract":"","PeriodicalId":199403,"journal":{"name":"Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125705931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Desmocollin-3 and Cancer desmocolin -3与癌症
Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8 Pub Date : 2017-10-27 DOI: 10.26717/BJSTR.2017.01.000473
B. Khamar
{"title":"Desmocollin-3 and Cancer","authors":"B. Khamar","doi":"10.26717/BJSTR.2017.01.000473","DOIUrl":"https://doi.org/10.26717/BJSTR.2017.01.000473","url":null,"abstract":"Desmocollin-3[DSC3] is one of the adhesion molecules of cadher in super family found in desmosome and is a major adhesive force of epithelial cells [1-6]. DSC3 is a transmembrane calcium-dependent glycoprotein produced by the endoplasmic reticulum,encoded by the DSC3 gene. DSC3 is expressed, mainly in basal and immediate suprabasal layers of the stratified squamous epithelia [7] like buccal mucosa, esophagus, cervix, fore skin tongue, trachea etc. [3,8]. As an adhesion molecule, DSC3 provides homophilic adhesion i.e. cells expressing DSC3 will adhere to each other at the site of expression but not with others; it also works as a receptor as well as ligand to participate in cell signaling [9].","PeriodicalId":199403,"journal":{"name":"Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2017-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132155890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信